Vanda Pharmaceuticals Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VNDA | NP5.F | ANRO | NRXP | NMRA | OVID | |
|---|---|---|---|---|---|---|
| Market cap | 234.62M | 205.50M | 914.34M | 107.81M | 106.35M | 535.12M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 19.4 | — | -7.3 | -7.1 | -0.9 | -7.5 |
| Price/book | 1.2 | -17.9 | 3.7 | -622.5 | 2.4 | 2.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −15.54% | −38.08% | +109.34% | −15.79% | −78.21% | +80.45% |
| Today | +3.47% | −0.50% | +2.64% | +11.16% | −0.86% | +14.17% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All VNDA news ›Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical
Prioritizing the patient and the clinician to drive meaningful change in kidney care and organ support therapies. Get in touch with Vantive, see product and security updates and learn how to do business with Vantive as a partner, supplier…
Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder
Study met its primary endpoint: timing of sleep onset shifted 37.1 minutes earlier versus placebo (p=0.022)60% of HETLIOZ® treated participants shifted sleep at least 30 minutes earlier, compared to 15% of the placebo armWASHINGTON, Sept.…
VNDA: SEC Form 8-K filed by Vanda Pharmaceuticals Inc.
Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. VNDA: SEC Form 8-K filed by Vanda…
Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program
Phase III clinical study of VQW-765 in adults with social anxiety disorder did not meet its primary endpointConsistent with prior studies, VQW-765 was safe and well toleratedWASHINGTON, Oct. 14, 2026 /PRNewswire/ -- Vanda Pharmaceuticals…
Analyzing Vanda Pharmaceuticals (NASDAQ:VNDA) and Talphera (NASDAQ:TLPH)
Posted by Kim Johansen on Nov 3rd, 2026 Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) and Talphera (NASDAQ:TLPH – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the…
Sinda Reports Third-Quarter 2026 Results, With $305.6 Million in Cash
TradingView Sinda Reports Third-Quarter 2026 Results, With $305.6 Million in Cash Sinda reported third-quarter 2026 results, highlighting ongoing drilling, site preparation for its exploration decline and a cash balance of $305.6
Novavax to Report Third Quarter 2026 Financial Results on November 5, 2026
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the Company plans to release its third quarter 2026 financial results before the open of the... GAITHERSBURG, Md., Oct. 29, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX)…
Vor Biopharma reports Q3 results
Vor Biopharma press release (VOR): Q3 Cash, cash equivalents and marketable securities were $481.6 million as of September 30, 2026, which are projected to fund - Cash, cash equivalents, and marketable securities were $481.6 million as of…
Vanda targets full-year 2026 total revenues greater than $240M as BYSANTI launch nears Q4
Vanda Q3 2026 earnings: revenue rose 24%, costs fell, and catalysts near. Earnings Call Insights: Vanda Pharmaceuticals (VNDA) Q3 2026 - "We're pleased with the strong revenue growth in the third quarter, increasing 24% year-over-year,…
Vanda Pharmaceuticals Inc. (VNDA) Q3 2026 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (VNDA) Q3 2026 Earnings Call October 28, 2026 4:30 PM EDT Kevin Moran - Senior VP, CFO & TreasurerMihael Polymeropoulos - Founder, President, CEO & Chairman of The Board Raghuram Selvaraju - H.C. Wainwright & Co,…
More from 1 other outlet
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- prnewswire.com4
- seekingalpha.com4
- stocktitan.net4
- tradingview.com3
- biospace.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 29 articles, not a forecast.